BioMarin (BMRN)’s Rare Disease Portfolio Generates Over $2.4 Billion in Annual Revenue
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is a pioneering biotechnology company specializing in the development and commercialization of therapies for…
Browsing Tag